Context Therapeutics Stock (NASDAQ: CNTX) stock price, news, charts, stock research, profile.
Open | $2.51 |
Close | $2.48 |
Volume / Avg. | 116.94K / 244.57K |
Day Range | $2.41 - $2.55 |
52 Wk Range | 0.77 - 2.75 |
Market Cap | $187.50M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 3.05% |
Days to Cover | 24.98 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.
Other companies in Context Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Esperion Therapeutics (NASDAQ:ESPR) and Alimera Sciences (NASDAQ:ALIM).
Context Therapeutics has a consensus price target of $7.38.
The stock price for Context Therapeutics (NASDAQ: CNTX) is $2.5 last updated August 20, 2024 at 4:40 PM EDT.
There are no upcoming dividends for Context Therapeutics.
Context Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Context Therapeutics.
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.